Press Release: Dr. Steven Keating, Our New Advisor

The Glioblastoma Drug Discovery Group is proud to have brain tumor survivor, Dr. Steven Keating, Ph.D., as a volunteer advisor. Dr. Keating is a strong proponent of curiosity and open patient data, having discovered his own brain tumor during a voluntary academic scan. Since Dr. Keating had a successful brain tumor removal surgery via awake craniotomy in 2014, he has a unique and powerful perspective on the future of brain tumor therapies. He will help us accelerate the development and characterization of our preclinical models for the adolescent and young adult age category. We are very excited to have Dr. Keating join our team!

This entry was posted on Wednesday, November 23rd, 2016 at 4:38 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply

Your email address will not be published. Required fields are marked *